Authors: Osama A. Hamad, Per H. Nilsson, Maria Lasaosa, Daniel Ricklin, John D. Lambris, Bo Nilsson, Kristina Nilsson Ekdahl
DOI: 10.1371/journal.pone.0012889
Abstract Summary
Researchers found that chondroitin sulfate A (CS-A), exposed on activated platelet surfaces, binds complement proteins C1q, C4BP, and factor H. CS-A-bound C1q amplifies immune complex binding to platelets, suggesting CS-A plays a role in immune complex diseases and adds a new binding mechanism for complement regulation on platelets.
Why Brain? ðŸ§
Chondroitin sulfate A on activated platelets binds complement proteins C1q, C4BP, and factor H, potentially amplifying immune complex binding and suggesting a role in immune complex diseases.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.



